Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.075,78
-0,44%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cellectar Biosciences Inc (CLRB) Cellectar Biosciences Inc (CLRB) Notizie

CLRB

Cellectar Biosciences (CLRB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CLRB
DataOraFonteTitoloSimboloCompagnia
13/01/202500:00GlobeNewswire Inc.Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare ConferenceNASDAQ:CLRBCellectar Biosciences Inc
11/12/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
10/12/202423:00GlobeNewswire Inc.Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate RestructuringNASDAQ:CLRBCellectar Biosciences Inc
18/11/202413:05GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
18/11/202412:46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLRBCellectar Biosciences Inc
14/11/202422:53Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
14/11/202422:47Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
14/11/202414:05GlobeNewswire Inc.Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225NASDAQ:CLRBCellectar Biosciences Inc
13/11/202422:45Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CLRBCellectar Biosciences Inc
12/11/202414:05GlobeNewswire Inc.Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of CancerNASDAQ:CLRBCellectar Biosciences Inc
11/11/202422:05GlobeNewswire Inc.Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024NASDAQ:CLRBCellectar Biosciences Inc
07/11/202412:40GlobeNewswire Inc.Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024NASDAQ:CLRBCellectar Biosciences Inc
01/11/202422:00GlobeNewswire Inc.Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-QNASDAQ:CLRBCellectar Biosciences Inc
29/10/202422:03Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
29/10/202421:56Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
26/08/202412:40GlobeNewswire Inc.Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s MacroglobulinemiaNASDAQ:CLRBCellectar Biosciences Inc
23/08/202423:00GlobeNewswire Inc.Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from NasdaqNASDAQ:CLRBCellectar Biosciences Inc
13/08/202412:40GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
08/08/202423:15GlobeNewswire Inc.UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024NASDAQ:CLRBCellectar Biosciences Inc
08/08/202422:05GlobeNewswire Inc.Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024NASDAQ:CLRBCellectar Biosciences Inc
24/07/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CLRBCellectar Biosciences Inc
23/07/202412:40GlobeNewswire Inc.Cellectar Biosciences’ Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom’s Macroglobulinemia Pivotal Study with 78% of Major Response Patients Remaining Progression Free at 18 MonthsNASDAQ:CLRBCellectar Biosciences Inc
22/07/202412:40GlobeNewswire Inc.Cellectar Biosciences Announces Exercise of Tranche B Warrants and Purchase of New Warrants for Approximately $19.4 million with the Potential to Raise Up to an Additional $73.3 MillionNASDAQ:CLRBCellectar Biosciences Inc
27/06/202412:40GlobeNewswire Inc.Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market LandscapeNASDAQ:CLRBCellectar Biosciences Inc
18/06/202423:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLRBCellectar Biosciences Inc
29/05/202412:40GlobeNewswire Inc.Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis FungoidesNASDAQ:CLRBCellectar Biosciences Inc
24/05/202422:46Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CLRBCellectar Biosciences Inc
16/05/202412:05Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:CLRBCellectar Biosciences Inc
14/05/202412:40GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
08/05/202412:40GlobeNewswire Inc.Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals DayNASDAQ:CLRBCellectar Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CLRB

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
IVG
Iveco Group NV
BIT
CPR
Davide Campari
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network